These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 37595560

  • 1. Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB).
    Epstein AL, Haag-Molkenteller C.
    Cell; 2023 Aug 17; 186(17):3523-3523.e1. PubMed ID: 37595560
    [Abstract] [Full Text] [Related]

  • 2. Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
    Paller AS, Guide SV, Ayala D, Gonzalez ME, Lucky AW, Bagci IS, Marinkovich MP.
    J Dermatolog Treat; 2024 Dec 17; 35(1):2350232. PubMed ID: 38724041
    [Abstract] [Full Text] [Related]

  • 3. Beremagene Geperpavec: First Approval.
    Dhillon S.
    Drugs; 2023 Aug 17; 83(12):1131-1135. PubMed ID: 37432558
    [Abstract] [Full Text] [Related]

  • 4. Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa.
    Raymakers AJN, Kesselheim AS, Mostaghimi A, Feldman WB.
    JAMA Dermatol; 2024 Mar 01; 160(3):297-302. PubMed ID: 38294784
    [Abstract] [Full Text] [Related]

  • 5. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
    Guide SV, Gonzalez ME, Bağcı IS, Agostini B, Chen H, Feeney G, Steimer M, Kapadia B, Sridhar K, Quesada Sanchez L, Gonzalez F, Van Ligten M, Parry TJ, Chitra S, Kammerman LA, Krishnan S, Marinkovich MP.
    N Engl J Med; 2022 Dec 15; 387(24):2211-2219. PubMed ID: 36516090
    [Abstract] [Full Text] [Related]

  • 6. Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper.
    Doolan BJ, McGrath JA, Mellerio JE.
    Br J Dermatol; 2024 Feb 16; 190(3):340-342. PubMed ID: 37936299
    [No Abstract] [Full Text] [Related]

  • 7. Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.
    Tovar Vetencourt A, Sayed-Ahmed I, Gomez J, Chen H, Agostini B, Carroll K, Parry T, Krishnan S, Sabater AL.
    N Engl J Med; 2024 Feb 08; 390(6):530-535. PubMed ID: 38324486
    [Abstract] [Full Text] [Related]

  • 8. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
    Gurevich I, Agarwal P, Zhang P, Dolorito JA, Oliver S, Liu H, Reitze N, Sarma N, Bagci IS, Sridhar K, Kakarla V, Yenamandra VK, O'Malley M, Prisco M, Tufa SF, Keene DR, South AP, Krishnan SM, Marinkovich MP.
    Nat Med; 2022 Apr 08; 28(4):780-788. PubMed ID: 35347281
    [Abstract] [Full Text] [Related]

  • 9. Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa.
    Khan A, Riaz R, Ashraf S, Akilimali A.
    Ann Med Surg (Lond); 2023 Dec 08; 85(12):6298-6301. PubMed ID: 38098548
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa.
    Chen M, O'Toole EA, Muellenhoff M, Medina E, Kasahara N, Woodley DT.
    J Biol Chem; 2000 Aug 11; 275(32):24429-35. PubMed ID: 10821839
    [Abstract] [Full Text] [Related]

  • 11. Fibroblasts as target cells for DEB gene therapy.
    Chen M, Woodley DT.
    J Invest Dermatol; 2006 Apr 11; 126(4):708-10. PubMed ID: 16541096
    [Abstract] [Full Text] [Related]

  • 12. Gene therapy for recessive dystrophic epidermolysis bullosa.
    Titeux M, Pendaries V, Hovnanian A.
    Dermatol Clin; 2010 Apr 11; 28(2):361-6, xii. PubMed ID: 20447504
    [Abstract] [Full Text] [Related]

  • 13. Overcoming obstacles for gene therapy for recessive dystrophic epidermolysis bullosa.
    Lanuti EL, Wikramanayake TC, Kirsner RS.
    J Invest Dermatol; 2011 Jan 11; 131(1):5. PubMed ID: 21157419
    [No Abstract] [Full Text] [Related]

  • 14. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A.
    Liu J, Wang L.
    Acta Dermatovenerol Croat; 2021 Dec 11; 29(3):164-166. PubMed ID: 34990346
    [Abstract] [Full Text] [Related]

  • 15. Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa.
    Vanden Oever M, Twaroski K, Osborn MJ, Wagner JE, Tolar J.
    Pediatr Res; 2018 Jan 11; 83(1-2):318-324. PubMed ID: 29593249
    [Abstract] [Full Text] [Related]

  • 16. QR-313, an Antisense Oligonucleotide, Shows Therapeutic Efficacy for Treatment of Dominant and Recessive Dystrophic Epidermolysis Bullosa: A Preclinical Study.
    Bornert O, Hogervorst M, Nauroy P, Bischof J, Swildens J, Athanasiou I, Tufa SF, Keene DR, Kiritsi D, Hainzl S, Murauer EM, Marinkovich MP, Platenburg G, Hausser I, Wally V, Ritsema T, Koller U, Haisma EM, Nyström A.
    J Invest Dermatol; 2021 Apr 11; 141(4):883-893.e6. PubMed ID: 32946877
    [Abstract] [Full Text] [Related]

  • 17. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
    Cutlar L, Greiser U, Wang W.
    Exp Dermatol; 2014 Jan 11; 23(1):1-6. PubMed ID: 24107073
    [Abstract] [Full Text] [Related]

  • 18. Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
    Eichstadt S, Barriga M, Ponakala A, Teng C, Nguyen NT, Siprashvili Z, Nazaroff J, Gorell ES, Chiou AS, Taylor L, Khuu P, Keene DR, Rieger K, Khosla RK, Furukawa LK, Lorenz HP, Marinkovich MP, Tang JY.
    JCI Insight; 2019 Oct 03; 4(19):. PubMed ID: 31578311
    [Abstract] [Full Text] [Related]

  • 19. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
    Dang N, Murrell DF.
    Exp Dermatol; 2008 Jul 03; 17(7):553-68. PubMed ID: 18558993
    [Abstract] [Full Text] [Related]

  • 20. siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa.
    Pendaries V, Gasc G, Titeux M, Tonasso L, Mejía JE, Hovnanian A.
    J Invest Dermatol; 2012 Jun 03; 132(6):1741-3. PubMed ID: 22336946
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.